Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-18-010837

Chief Technology Officer & EVP sold 14,279 shares at $7.58 ($108,266)

From the SEC's structured data for this filing

Trades in this filing

Aunins John G. · Chief Technology Officer & EVP

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-04-25 Sale : show line 1 in the form −14,279 $7.58 $108,266 184,485 D
Open-market sales · 14,279 sh · avg $7.58 · $108,266
Loading xslF345X03/doc4.xml…